X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
investigating or analysing materials by determining theirchemical or physical properties (52) 52
measuring (52) 52
physics (52) 52
testing (52) 52
animals (25) 25
male (24) 24
humans (22) 22
rats (20) 20
chemistry (17) 17
metallurgy (17) 17
peptides (16) 16
female (15) 15
organic chemistry (14) 14
index medicus (13) 13
endocrinology & metabolism (11) 11
insulin resistance (10) 10
multidisciplinary sciences (10) 10
middle aged (9) 9
rats, wistar (8) 8
adult (7) 7
aged (7) 7
diabetes (7) 7
disease models, animal (7) 7
glucose (7) 7
environmental sciences (6) 6
iodide peroxidase - immunology (6) 6
research (6) 6
risk factors (6) 6
thyrotropin - blood (6) 6
rat (5) 5
slovakia (5) 5
thyroid gland - drug effects (5) 5
adolescents (4) 4
beer (4) 4
biochemistry (4) 4
blood glucose - metabolism (4) 4
diabetes mellitus, type 2 - drug therapy (4) 4
enzymology (4) 4
hydrocarbons, chlorinated - toxicity (4) 4
insulin - metabolism (4) 4
iodine - urine (4) 4
metabolism (4) 4
mice (4) 4
microbiology (4) 4
mutation or genetic engineering (4) 4
nutrition & dietetics (4) 4
pcbs (4) 4
physiological aspects (4) 4
polychlorinated-biphenyls (4) 4
rats, sprague-dawley (4) 4
skeletal-muscle (4) 4
spirits (4) 4
urinary iodine (4) 4
vinegar (4) 4
wine (4) 4
adolescent (3) 3
autoantibodies (3) 3
autoantibodies - blood (3) 3
biochemistry & molecular biology (3) 3
blood glucose - drug effects (3) 3
blood-pressure (3) 3
breast-cancer (3) 3
chemistry, medicinal (3) 3
cholesterol (3) 3
cholesterol, hdl - blood (3) 3
compositions or test papers therefor (3) 3
condition-responsive control in microbiological orenzymological processes (3) 3
crystallography, x-ray (3) 3
dependent insulinotropic polypeptide (3) 3
diabetes mellitus, type 2 - blood (3) 3
diabetes-mellitus (3) 3
diabetic rats (3) 3
diet (3) 3
dietary fats - pharmacology (3) 3
dioxin-like pcbs (3) 3
dipeptidyl peptidase 4 - metabolism (3) 3
environmental monitoring (3) 3
environmental pollutants - blood (3) 3
hydrocarbons, chlorinated - blood (3) 3
hypoglycemic agents - administration & dosage (3) 3
hypoglycemic agents - pharmacology (3) 3
insulin - blood (3) 3
insulin resistance - physiology (3) 3
iodine deficiency (3) 3
lipid metabolism (3) 3
measuring or testing processes involving enzymes, nucleicacids or microorganisms (3) 3
medicine, research & experimental (3) 3
muscle, skeletal - metabolism (3) 3
obesity - genetics (3) 3
ovariectomy (3) 3
pesticides (3) 3
pioglitazone (3) 3
polychlorinated biphenyls (3) 3
polychlorinated biphenyls - blood (3) 3
ppar gamma - agonists (3) 3
processes of preparing such compositions (3) 3
rats, zucker (3) 3
receptors, glucagon - metabolism (3) 3
risk (3) 3
slovakia - epidemiology (3) 3
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (115) 115
French (32) 32
German (10) 10
Spanish (3) 3
Chinese (2) 2
Japanese (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 12/2014, Volume 21, Issue 1, pp. 27 - 36
Journal Article
Journal of Bone and Mineral Metabolism, ISSN 0914-8779, 11/2015, Volume 33, Issue 6, pp. 625 - 641
Pioglitazone, the peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist is an effective therapy for type 2 diabetes, but has been associated with... 
Fenofibrate | PPAR-α agonist | Medicine & Public Health | Orthopedics | Pioglitazone | Metabolic Diseases | Histomorphometry | PPAR-γ agonist | MEDICINE, RESEARCH & EXPERIMENTAL | CONTROLLED-TRIAL | COMPOUND | GAMMA AGONIST PIOGLITAZONE | FAT DISTRIBUTION | DECREASES | BODY-FAT | MINERAL DENSITY | ENDOCRINOLOGY & METABOLISM | ACTIVATED-RECEPTOR-GAMMA | PPAR-gamma agonist | PPAR-GAMMA | ROSIGLITAZONE | PPAR-alpha agonist | Bone and Bones - pathology | Femur - pathology | Tomography, X-Ray Computed | Femur - diagnostic imaging | Thiazolidinediones - administration & dosage | Tibia - pathology | Femur Neck - diagnostic imaging | Fenofibrate - pharmacology | Biomechanical Phenomena - drug effects | Compressive Strength - drug effects | Female | Densitometry | Thiazolidinediones - pharmacology | Tibia - physiopathology | Diaphyses - pathology | Femur Neck - pathology | Diaphyses - diagnostic imaging | Ovariectomy | Tibia - diagnostic imaging | Fenofibrate - administration & dosage | Femur - drug effects | Lumbar Vertebrae - drug effects | Femur - physiopathology | Tibia - drug effects | Absorptiometry, Photon | Rats, Sprague-Dawley | Bone and Bones - physiopathology | Animals | Diaphyses - drug effects | Diaphyses - physiopathology | Femur Neck - physiopathology | Lumbar Vertebrae - pathology | Femur Neck - drug effects | Type 2 diabetes | Biomechanics | Bones | Hypoglycemic agents | Density
Journal Article
Journal Article
Science Translational Medicine, ISSN 1946-6234, 10/2013, Volume 5, Issue 209, pp. 209ra151 - 209ra151
We report the discovery and translational therapeutic efficacy of a peptide with potent, balanced co-agonism at both of the receptors for the incretin hormones... 
MEDICINE, RESEARCH & EXPERIMENTAL | BODY-WEIGHT | GLYCEMIC CONTROL | HIGH-FAT DIET | GLUCOSE-INTOLERANCE | ENTEROINSULAR AXIS | PANCREATIC BETA-CELLS | DEPENDENT INSULINOTROPIC POLYPEPTIDE | GASTRIC-INHIBITORY POLYPEPTIDE | LIPOPROTEIN-LIPASE | PEPTIDE YY3-36 | CELL BIOLOGY | Acylation - drug effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Middle Aged | Male | Rodentia - metabolism | Weight Loss - drug effects | Hyperglycemia - drug therapy | Young Adult | Incretins - pharmacology | Adult | Female | Gastric Inhibitory Polypeptide - pharmacology | Receptors, Glucagon - agonists | Glucose Tolerance Test | Glucagon-Like Peptide 1 - analogs & derivatives | Glucagon-Like Peptide 1 - pharmacology | Rats | Receptors, Glucagon - metabolism | Treatment Outcome | Haplorhini - metabolism | Gastric Inhibitory Polypeptide - administration & dosage | Peptides - pharmacology | Insulin - metabolism | Animals | Glucagon-Like Peptide-1 Receptor | Adolescent | Aged | Mice | Venoms - pharmacology | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Receptors, Gastrointestinal Hormone | Incretins - administration & dosage | Liraglutide | Medicin och hälsovetenskap | Medicinsk bioteknologi (inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinsk bioteknologi
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 01/2011, Volume 10, Issue 1, pp. 7 - 7
Journal Article
Current Topics in Medicinal Chemistry, ISSN 1568-0266, 03/2007, Volume 7, Issue 6, pp. 547 - 555
Type 2 diabetes is a chronic metabolic disease characterized by the presence of both fasting and postprandial hyperglycemia which is a result of pancreas... 
Incretins | DPP-IV | GLP-1 | Diabetes | GIP | incretins | CHEMISTRY, MEDICINAL | FOOD-INTAKE | BETA-CELL FUNCTION | BODY-WEIGHT | GLUCAGON-LIKE PEPTIDE-1 | METFORMIN-TREATED PATIENTS | LIRAGLUTIDE NN2211 | DEPENDENT INSULINOTROPIC POLYPEPTIDE | IMPROVED GLYCEMIC CONTROL | GLP-1 7-36 AMIDE | diabetes | GLUCOSE-TOLERANCE
Journal Article
Journal Article
Chemosphere, ISSN 0045-6535, 2007, Volume 67, Issue 9, pp. S379 - S385
Journal Article
Chemosphere, ISSN 0045-6535, 2007, Volume 69, Issue 1, pp. 118 - 127
Journal Article